Open access · CC-BY
via OpenAlex
Therapies for Prevention and Treatment of Alzheimer’s Disease
Jesus Mendiola-Precoma, Laura C. Berumen, Karla Padilla, Guadalupe García‐Alcocer
BioMed Research International · 2016 · ▲ 240 citations
Abstract
Alzheimer's disease (AD) is the most common cause of dementia associated with a progressive neurodegenerative disorder, with a prevalence of 44 million people throughout the world in 2015, and this figure is estimated to double by 2050. This disease is characterized by blood-brain barrier disruption, oxidative stress, mitochondrial impairment, neuroinflammation, and hypometabolism; it is related to amyloid-β peptide accumulation and tau hyperphosphorylation as well as a decrease in acetylcholine levels and a reduction of cerebral blood flow. Obesity is a major risk factor for AD, because it induces adipokine dysregulation, which consists of the release of the proinflammatory adipokines and decreased anti-inflammatory adipokines, among other processes. The pharmacological treatments for AD can be divided into two categories: symptomatic treatments such as acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists and etiology-based treatments such as secretase inhibitors, amyloid binders, and tau therapies. Strategies for prevention of AD through nonpharmacological treatments are associated with lifestyle interventions such as exercise, mental challenges, and socialization as well as caloric restriction(definition) and a healthy diet. AD is an important health issue on which all people should be informed so that prevention strategies that minimize the risk of its development may be implemented.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2016/2589276
- Canonical
- link ↗
- Fetched
- 2026-06-05 MST
Cite this
APA
Mendiola-Precoma, J., Berumen, L.C., Padilla, K., & García‐Alcocer, G. (2016). Therapies for Prevention and Treatment of Alzheimer’s Disease. <em>BioMed Research International</em>. https://doi.org/10.1155/2016/2589276
Vancouver
Mendiola-Precoma J, Berumen LC, Padilla K, García‐Alcocer G. Therapies for Prevention and Treatment of Alzheimer’s Disease. BioMed Research International. 2016. doi:10.1155/2016/2589276.
BibTeX
@article{jesus2016Therap,
title = {Therapies for Prevention and Treatment of Alzheimer’s Disease},
author = {Jesus Mendiola-Precoma and Laura C. Berumen and Karla Padilla and Guadalupe García‐Alcocer},
journal = {BioMed Research International},
year = {2016},
doi = {10.1155/2016/2589276},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Antioxidants and Redox Signaling 2011
Preprint · OA
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
Current Alzheimer Research 2021
Preprint · CC-BY
Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
Cells 2026
Open access · OA
Mitochondrial Dysfunction in Alzheimer's Disease and Mitochondria-Targeted Therapeutics.
Rennes University Hospital 2021
Open access · US-GOV
ARIADE : Augmented Reality for Improving Autonomy in Dementia. Creation, Implementation and Testing of an Augmented Reality Tool to Help People With Alzheimer's Type Dementia in Their Travels.
Nature Communications 2025
Open access · CC-BY
An integrative systems-biology approach defines mechanisms of Alzheimer’s disease neurodegeneration
Journal of Parkinson s Disease 2017
Open access · CC-BY